CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 101 enrolled
Drug / intervention
Nonexercise control group +3 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01129115
NCT01129115Early Ph 1Completed

Dose Response Study of Exercise for Age-related Cognitive Changes

Jeff Burns, MD·interventional·Posted May 24, 2010·Updated Feb 15, 2016

In Brief

A Early Phase 1 clinical trial evaluating Nonexercise control group, Aerobic Exercise Group 1, and 2 other interventions for Alzheimer's Disease. Completed, enrolled 101 participants across 1 site.

Detailed Summary

This is a randomized, 26-week study of supervised exercise assessing three doses of exercise in sedentary individuals 65 years of age and over with age-related cognitive changes. A total of 100 subjects (n=25 in each of four groups) will be randomized to a non-aerobic control group, 75 minutes, 150 minutes, or 225 minutes a week of moderate intensity aerobic exercise spread over 3 to 5 days a week for 26 weeks. These exercise doses represent 50%, 100%, or 150% of the recommended exercise dose. Participants will be directly supervised during all exercise sessions for the first two months after which direct supervision will occur during at least one session a week. This is intended to provide increased flexibility while also maintaining direct contact with the participant to enhance adherence. Aerobic fitness, physical function, and cognition will be assessed at baseline and 26 weeks to examine the dose-response relationships.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 24, 2010
Enrollment StartMay 1, 2010
Primary CompletionFeb 1, 2014
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.1 years ago

Interventions

Nonexercise control groupbehavioral

Participants randomized to the nonexercise control group will be asked to maintain their current level of physical activity during the 26-week active study period. They will perform outcome assessments and receive the same telephone checks as the exercise group at baseline, 26 and 52 weeks. The purpose of including a non-exercise control group is to allow adequate comparisons with the low, medium and high exercise dose groups on changes in cognitive and physiologic outcome measures.

Aerobic Exercise Group 1behavioral

The 50% group will perform 75 minutes a week of moderate intensity exercise spread over 3 days.

Aerobic Exercise Group 2behavioral

The 100% group will perform 150 minutes a week of exercise over 3 - 5 days

Aerobic Exercise Group 3behavioral

The 150% group will perform 225 minutes a week of exercise over 4 - 5 days.